Outset Medical (OM) Net Margin (2019 - 2026)

Outset Medical (OM) has reported Net Margin for 8 consecutive years, with 56.85% the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Margin rose 216.0% year-over-year to 56.85% in Q2 2026; TTM through Jun 2026 was 48.03%, a 3404.0% increase from a year earlier, with the FY2025 full-year figure at 53.52%, up 5905.0% from the prior year.
• Net Margin was 56.85% for Q2 2026 at Outset Medical, up from 68.11% in the prior quarter.
• Over five years, Net Margin peaked at 6.15% in Q4 2025 and troughed at 174.96% in Q2 2022.
• A 5-year average of 105.21% and a median of 121.49% in 2022 frame the typical range for Net Margin.
• Across the five-year window, Net Margin slumped 5516 bps in 2022 and soared 8085 bps in 2025, its largest moves.
• Over 5 years, Net Margin stood at 129.48% in 2022, then rose by 2 bps to 126.53% in 2023, then surged by 31 bps to 87.01% in 2024, then jumped by 93 bps to 6.15% in 2025, then tumbled by 824 bps to 56.85% in 2026.
• The last three Net Margin figures came in at 56.85% (Q2 2026), 68.11% (Q1 2026), and 6.15% (Q4 2025), per Business Quant data.